2022 BRACE Award Venture Competition
The BRACE Award Venture Competition Selection Committee is comprised of a combination of world-class life sciences industry professionals, investors and entrepreneurs from within the extensive network of the Asian Fund for Cancer Research (AFCR). Its members will determine the winning business among the event’s semi-finalists. The winner will receive the equivalent of up to US$600,000 in equity investment funding from AFCR, which will serve as early seed money for proof of concept and proof of value on the path to clinical trials and, eventually, to new effective therapeutics that could save patients’ lives.
Ready to do more? DONATE NOW and help us double the impact for early-stage oncology start-ups that are creating life-saving innovations!